Clinical Trial

Intravenous Lidocaine for Postoperative Fatigue After Laparoscopic TAPP Inguinal Hernia Repair

Study acronym: LIDO-TAPP
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2026 (before its estimated August 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective randomized controlled study aims to evaluate the effect of perioperative intravenous lidocaine infusion on postoperative fatigue syndrome in patients undergoing elective laparoscopic TAPP inguinal hernia repair. Participants will be randomly assigned to receive either intravenous lidocaine infusion or standard perioperative management without lidocaine. The primary objective is to assess postoperative fatigue and recovery quality. Secondary outcomes include postoperative pain, analgesic consumption, nausea-vomiting, mobilization time, and length of hospital stay.
Trial Details
NCT Number NCT07612839
Lead Sponsor Hakan Emirkadı
Conditions Postoperative Fatigue Syndrome, Inguinal Hernia Unilateral
Enrollment 80 participants
Start Date 2026-06-05
Primary Completion 2026-08-10 (estimated)
Study Completion 2026-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-29